What if a simple measure could help predict your heart health and potentially save your life? Heart disease is a major health issue, often complicated by the condition of the heart's tiny blood vessels, which can be hard to evaluate. A recent analysis looked at microvascular resistance reserve, a new way to assess how well these small blood vessels are functioning. The findings showed that higher levels of this measure are strongly associated with a lower risk of major heart problems, like heart attacks. Specifically, patients with low microvascular resistance reserve faced more than double the risk of serious heart events compared to those with higher levels. This is especially important for those experiencing acute coronary syndrome, a severe form of heart disease. While this research is promising, it’s important to note that more studies are needed to confirm these results and to see how best to use this information in everyday care. For now, understanding microvascular resistance could be a game-changer in how doctors evaluate and treat heart disease, leading to better outcomes for patients.
Could Understanding Microvascular Resistance Save Lives in Heart Disease?
Plain Language Summary
What this means for you:
Knowing your microvascular health could be key to reducing serious heart risks and improving treatment outcomes. What this means for you:
Knowing your microvascular health could be key to reducing serious heart risks and improving treatment outcomes. View Original Abstract ↓
BACKGROUND: Microvascular resistance reserve (MRR) is a novel index for evaluating coronary microvascular function independently of epicardial disease. Its prognostic significance in coronary artery disease (CAD) remains uncertain.
OBJECTIVES: The aim of this study was to assess the association between MRR and adverse cardiovascular outcomes across various CAD presentations.
METHODS: A systematic review and meta-analysis was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. MEDLINE and Embase were searched from January 2019 to January 2025 for prospective studies reporting HRs for major adverse cardiovascular events in relation to MRR. Risk for bias was assessed using the Quality in Prognosis Studies tool. Pooled HRs were calculated using a random-effects model; heterogeneity was evaluated using the I statistic.
RESULTS: Five studies (n = 3,186) were included. Higher MRR was significantly associated with lower risk for adverse events (HR per unit increase: 0.75; 95% CI: 0.64-0.88; I = 80.9%). When dichotomized, low MRR conferred a more than 2-fold increased risk for major adverse cardiovascular events (HR: 2.39; 95% CI: 1.66-3.43). Subgroup analysis showed a stronger prognostic effect for ST-segment elevation myocardial infarction (HR: 0.46) vs stable CAD (HR: 0.86; P for interaction < 0.0001). Threshold analysis identified MRR ≥ 3 as optimal for sensitivity (58.9%) and rule-out performance, while lower thresholds improved specificity.
CONCLUSIONS: MRR is a robust, independent predictor of cardiovascular outcomes of both acute and chronic CAD. Its prognostic impact is particularly pronounced for acute coronary syndrome. A threshold of 3 provides the best prognostic balance, supporting its integration into invasive physiological assessment for risk stratification.